Back
4D Molecular Therapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison
Buy
55
FDMT
4D Molecular Therapeutics
Last Price:
26.24
Seasonality Move:
-18.33%
Buy
69
VRTX
Vertex Pharmaceuticals
Last Price:
418.70
Seasonality Move:
8.99%
Buy
55
4D Molecular Therapeutics (FDMT)
is a Buy
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $26.79. The Score for FDMT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- FDMT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $410.30. The Score for VRTX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $26.79
The current trend is relatively stagnant and FDMT is experiencing slight buying pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $410.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.59 | Sell |
| Relative Strength Index (14 RSI): | 51.86 | Buy |
| Chaikin Money Flow: | 70295 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.56 - 27.56) | Buy |
| Bollinger Bands (100): | (19.92 - 30.06) | Buy |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.25 | Sell |
| Relative Strength Index (14 RSI): | 58.89 | Buy |
| Chaikin Money Flow: | 744959 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (395.24 - 404.8) | Buy |
| Bollinger Bands (100): | (402.19 - 427.55) | Sell |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.38 | Buy |
| 20-day SMA: | 25.57 | Buy |
| 50-day SMA: | 28.29 | Sell |
| 200-day SMA: | 19.44 | Buy |
| 8-day EMA: | 25.9 | Buy |
| 20-day EMA: | 26.12 | Buy |
| 50-day EMA: | 26.52 | Buy |
| 200-day EMA: | 21.8 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 400.33 | Buy |
| 20-day SMA: | 398.63 | Buy |
| 50-day SMA: | 408.27 | Buy |
| 200-day SMA: | 385.06 | Buy |
| 8-day EMA: | 402.19 | Buy |
| 20-day EMA: | 401.65 | Buy |
| 50-day EMA: | 405.74 | Buy |
| 200-day EMA: | 386.85 | Buy |
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.78 per share, an increase this year of $1.95 per share, and an increase next year of $1.14 per share.
4D Molecular Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||